Abstract
Patients with atrial fibrillation (AF) have an increased stroke risk. This can be managed by oral anticoagulation (OAC) but a substantial number of patients are ineligible. The left atrial appendage (LAA) is the predominant thrombus source in AF, thus LAA management may reduce stroke risk. We
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
